NeurOp Corporation and Emory University Scientists Target Cognitive and Mental Health Disorders  
2/19/2013 9:25:46 AM

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. has formed a research collaboration with Emory University to study modulation of certain brain cell receptors and its possible impact on several serious cognitive and mental health disorders - schizophrenia, post-traumatic stress disorder (PTSD), and Parkinson’s and Alzheimer’s diseases. NeurOp, a biopharmaceutical company, is working with Emory to accelerate NMDA (N-methyl D-aspartate) receptor research into potential new treatments for these areas of medical need.